Search results
Bears are Losing Control Over Aprea Therapeutics, Inc. (APRE), Here's Why It's a 'Buy' Now
Zacks via Yahoo Finance· 1 year agoAprea Therapeutics, Inc. (APRE) appears to have found support after losing some value lately, as...
Aprea (APRE) Rises on Advancing Lead Drug to Clinical Studies
Zacks via Yahoo Finance· 1 year agoShares of Aprea Therapeutics APRE were up 12% on Jan 11 after management announced that it dosed the...
Jazz Pharma (JAZZ) Gets EU Nod for Cancer Drug Enrylaze
Zacks via Yahoo Finance· 7 months agoThe approval is based on data from a phase II/III study, which showed that treatment with Jazz's...